News and Trends 28 Nov 2022
Deep Science Ventures and AbbVie to create companies to target inflammatory diseases
Deep Science Ventures (DSV), a London-based venture creator, is teaming up with AbbVie, a global pharmaceutical company, to build one or more new companies targeting immune-mediated inflammatory diseases. Together, the…
